vimarsana.com

Page 3 - Idaho Molecular News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Co-Diagnostics Reports Full Year 2021 Financial Results

/PRNewswire/ Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular.

United statesKirk ririeDwight eganCarl wittwerExchange commissionConceptions incDiagnostics incIdaho molecular incUnited kingdom health security agencyCentral drugs standard control organizationLogix smartCo diagnostic chief executive officerBrian brownChief financial officerJesse montgomeryChief scientific

Co-Diagnostics to Seek FDA EUA for At-Home PCR Diagnostic System, COVID Test in Q1

Newly merged with a firm founded by BioFire Diagnostics alums, Co-Diagnostics plans to develop small panels for the system with up to six targets.

University of utahUnited statesSalt lakeKirk ririeDwight eganCarl wittwerBiofire idaho technologyIdaho technologyLucira healthConceptions incorporatedDrug administrationCue healthIdaho molecularAdvanced conceptions incorporatedEmergency use authorizationMolecular diagnostics

Co-Diagnostics Buys Idaho Molecular

The deal was made in order to streamline the commercialization of the Eikon platform and YourTest PCR device.

United statesDwight eganConceptions incIdaho molecular incDiagnostics incCoprimer technologyIdaho molecularAdvanced conceptions

Co-Diagnostics, Inc Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

/PRNewswire/ Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of.

United statesKirk ririeDwight eganCarl wittwerConceptions incDiagnostics inc nasdaqIdaho molecular incDiagnostics incCompany scientific advisory boardIdaho molecularAdvanced conceptionsScientific advisoryCo diagnostics

Co-Diagnostics, Inc Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care Platform

/PRNewswire/ Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of.

United statesKirk ririeDwight eganCarl wittwerConceptions incDiagnostics inc nasdaqIdaho molecular incDiagnostics incCompany scientific advisory boardIdaho molecularAdvanced conceptionsScientific advisoryCo diagnostics

vimarsana © 2020. All Rights Reserved.